Bellevue Life Sciences Acquisition Corporation (BLACU) News

Form DEF 14A - Other definitive proxy statements

Form PRE 14A - Other preliminary proxy statements

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 425 - Prospectuses and communications, business combinations

Form 8-K - Current report

Bellevue Life Sciences Acquisition Corp. and OSR Holdings Sign an Exclusive Letter of Intent for a Business Combination

Bellevue Life Sciences Acquisition Corp. and OSR Holdings Sign an Exclusive Letter of Intent for a Business Combination PR Newswire BELLEVUE...

Form 8-K - Current report

Current Report Filing (8-k)

false000184042500018404252023-06-082023-06-080001840425blac:UnitsEachConsistingOfOneShareOfCommonStockOneRedeemableWarrantAndOneRightMember2023-06...

Quarterly Report (10-q)

UNITED STATES  SECURITIES AND EXCHANGE COMMISSION  WASHINGTON, DC 20549   FORM 10-Q  ...

Notification That Quarterly Report Will Be Submitted Late (nt 10-q)

      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 12b-25...

Annual Report (10-k)

    UNITED STATES  SECURITIES AND EXCHANGE COMMISSION  WASHINGTON, DC 20549   FORM 10-K...

Statement of Changes in Beneficial Ownership (4)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...

Statement of Changes in Beneficial Ownership (4)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...

Statement of Changes in Beneficial Ownership (4)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT...